News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Revolution Medicines and Iambic Form AI-Driven Research Collaboration to Advance Drug Discovery
Thursday, July 10, 2025Revolution Medicines Inc and Iambic Therapeutics have announced a multiyear technology and research collaboration aimed at identifying new drug candidates using artificial intelligence AI
Sartorius Stedim Biotech and Sensible Biotechnologies Collaborate to Scale Up Cell-Based mRNA Production Platform
Thursday, July 10, 2025Sartorius Stedim Biotech a global partner to the biopharmaceutical industry has entered into a Memorandum of Understanding MoU with Sensible Biotechnologies to advance the scaleup of Sensibles cellbased platform
Neuraxpharm and Dizlin Pharmaceuticals Sign Global Agreement to Co-Develop Wearable Therapy for Advanced Parkinson’s Disease
Wednesday, July 09, 2025Neuraxpharm Group a European pharmaceutical company focused on central nervous system CNS disorders has entered into a global codevelopment agreement with Swedenbased Dizlin Pharmaceuticals
Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Gene Therapy Towards Clinical Trials for Type 1 Diabetes
Wednesday, July 09, 2025Amarna Therapeutics a biotechnology company focused on gene therapies has finalised an agreement with NorthX Biologics to accelerate the development of its gene therapy platform Nimvec
SCG Cell Therapy Receives IND Clearance from China NMPA for SCG101V in Chronic Hepatitis B
Tuesday, July 08, 2025SCG Cell Therapy Pte Ltd SCG a clinicalstage biotechnology company developing TCR T cell therapies for infectious diseases and related cancers has received approval from the China National Medical Products Administration NMPA
Mustang Bio Receives FDA Orphan Drug Designation for MB-101 to Treat Astrocytomas and Glioblastoma
Tuesday, July 08, 2025Mustang Bio Inc a clinicalstage biopharmaceutical company focused on developing cell therapies for hardtotreat cancers has been granted Orphan Drug Designation by the US Food and Drug Administration FDA
Brii Biosciences Licenses Rights to BRII-693 in Greater China to Joincare Group
Friday, July 04, 2025Brii Biosciences Limited Brii Bio a biotechnology firm focused on addressing diseases with significant unmet medical needs has signed a licensing and technology transfer agreement with Joincare Pharmaceutical Group Industry Co
Imfinzi Approved in EU as First Perioperative Immunotherapy for Muscle-Invasive Bladder Cancer
Friday, July 04, 2025AstraZenecas Imfinzi durvalumab has been approved by the European Commission for use in adult patients with resectable muscleinvasive bladder cancer MIBC The treatment involves a combination of Imfinzi with gemcitabine and cisplatin as neoadjuvant th...
Instil Bio Receives FDA Clearance to Begin Phase 1 Trial of AXN-2510 for Relapsed or Refractory Solid Tumours
Thursday, July 03, 2025Instil Bio Inc a clinicalstage biopharmaceutical company listed on NASDAQ TIL has announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for AXN This is a PDLxVEGF bispecific antibody developed...
Jazz Pharmaceuticals Gains Conditional EU Approval for Ziihera® to Treat Advanced HER2-Positive Biliary Tract Cancer
Wednesday, July 02, 2025Jazz Pharmaceuticals plc has received conditional marketing authorisation from the European Commission EC for Ziihera zanidatamab as a treatment for adults with unresectable locally advanced or metastatic HERpositive biliary tract cancer BTC who have...
